Market Movers

China Vanke’s Stock Price Plummets to 3.88 HKD, Witnessing a Sharp Decline of 6.28%

By November 26, 2025 No Comments

China Vanke (2202)

3.88 HKD -0.26 (-6.28%) Volume: 140.09M

China Vanke’s stock price stands at 3.88 HKD, experiencing a significant drop of -6.28% in this trading session, with a considerable trading volume of 140.09M. The leading real estate company’s stock price has seen a substantial decrease YTD, with a percentage change of -26.28%, reflecting a challenging market environment.


Latest developments on China Vanke

China Vanke (H) stock price experienced significant movements today as concerns over state support mounted, leading to a slump in its bonds. The company also made headlines by selling off all its shares in KE Holdings. These events have contributed to increased volatility in China Vanke (H) stock price, as investors react to the latest developments surrounding the real estate giant.


A look at China Vanke Smart Scores

FactorScoreMagnitude
Value5
Dividend1
Growth2
Resilience2
Momentum2
OVERALL SMART SCORE2.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Vanke (H) has been given a high score of 5 for its value, indicating a positive long-term outlook in terms of its financial health and potential for growth. This suggests that the company is undervalued and could offer good investment opportunities for those looking to capitalize on its potential.

However, the company has received lower scores in other areas such as dividend, growth, resilience, and momentum, with scores ranging from 1 to 2. This indicates that while China Vanke (H) may have strong value, there are some weaknesses in other key areas that could impact its overall performance in the long run. Investors should carefully consider all factors before making any decisions regarding this property development company.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars